Interestingly, some animal studies have explored BPC-157 as a post-surgical adjunct, with promising results in models of tendon-to-bone reattachment
BPC-157 and Exercise: What to Expect in Daily Life on This Peptide At a glance Peptide class / 15-amino-acid gastric-derived sequence (BPC = Body Protection Compound) Typical research dose / 200 to 500 mcg per day, subcutaneous or intramuscular Primary studied benefit / tendon and ligament repair, muscle healing, GI mucosal protection Onset of reported effects / 2 to 6 weeks in most patient-reported outcome surveys Human RCT status / No Phase III RCTs published as of July 2025
BPC-157 and TB-500 are combined in a single 20 mg vial
This three-compound stack represents a more aggressive but potentially faster recovery approach
Preclinical data across animal and in vitro models consistently points to roles in intestinal lining integrity, inflammation modulation, and mucosal tissue repair
Some peptides survive the digestive tract and can be taken orally